Esophageal Cancer
Copyright ©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 7, 2007; 13(5): 676-682
Published online Feb 7, 2007. doi: 10.3748/wjg.v13.i5.676
Table 1 GST immunohistochemical expression according to a semiquantitative score in various types of mucosal lesions of the esophagus
HistologyScore (mean ± SD)
Normal epithelium (Control group)a (n = 7)2.85 ± 0.24
Reflux esophagitis (n = 7)1.14 ± 0.24
Barrett’s metaplasia (n = 14)1.60 ± 0.34
Barrett’s metaplasia and reflux esophagitis (n = 8)1.12 ± 0.35
Barrett’s metaplasia and dysplasiab (n = 7)0.58 ± 0.37
Adenocarcinomabc (n = 8)0.18 ± 0.25
Table 2 MMP-9 immunohistochemical expression according to a semiquantitative score in various types of mucosal lesions of the esophagus
HistologyScore (mean ± SD)
Normal epithelium (Control goup)b (n = 7)0.28 ± 0.39
Reflux esophagitis (n = 7)1.71 ± 0.39
Barrett’s metaplasia (n = 14)1.46 ± 0.41
Barrett’s metaplasia and reflux esophagitis (n = 8)1.75 ± 0.26
Barrett’s metaplasia and dysplasiaa (n = 7)2.16 ± 0.25
Adenocarcinomaac (n = 8)2.62 ± 0.35